Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gérard Jaouen

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Chemical Society Reviews|October 22, 2015
Ferrocifen type anti cancer drugsGérard Jaouen, Anne Vessières, Siden Top
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
4-(3-Methoxy-phen-oxy)butyric acidJulia Heilmann-Brohl, Gérard Jaouen, Michael Bolte
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 13, 2005
A new efficient route to chiral 1,3-disubstituted ferrocenes: application to the syntheses of (R(p))- and (S(p))-17alpha-[(3'-formylferrocenyl)ethynyl]estradiolBenoît Ferber, Siden Top, Richard Welter, et al.
Cancers|June 2, 2021
Ferrocifen Loaded Lipid Nanocapsules: A Promising Anticancer Medication against Multidrug Resistant TumorsPierre Idlas, Elise Lepeltier, Gérard Jaouen, et al.
Steroids|January 13, 2004
Are the 11-oxo-steroids really so hindered towards organometallic compounds?Vincent Lecomte, Elie Stéphan, Jacqueline Vaissermann, et al.
The Journal of Organic Chemistry|April 24, 2004
Versatile use of hindered oxalates for the stereoselective preparation of novel 11-modified androst-5-ene derivativesVincent Lecomte, Elie Stéphan, Marie-Noelle Rager, et al.
Dalton Transactions (Cambridge, England : 2003)|May 23, 2012
Targeted therapy vs. DNA-adduct formation-guided design: thoughts about the future of metal-based anticancer drugsGianni Sava, Gérard Jaouen, Elizabeth A Hillard, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|April 11, 2002
FT-IR observation of covalent labelling of lysozyme crystals by organometallic complexes of transition metalsDarren Egan, Michèle Salmain, Patrick McArdle, et al.
Bioconjugate Chemistry|September 22, 2005
Sulfhydryl-selective, covalent labeling of biomolecules with transition metallocarbonyl complexes. Synthesis of (eta5-C5H5)M(CO)3(eta1-N-maleimidato) (M = Mo, W), X-ray structure, and reactivity studiesBogna Rudolf, Marcin Palusiak, Janusz Zakrzewski, et al.
Metallomics : Integrated Biometal Science|November 12, 2010
Synthesis and biodistribution of [99mTc]-N-[4-nitro-3-trifluoromethyl-phenyl] cyclopentadienyltricarbonyltechnetium carboxamide, a nonsteroidal antiandrogen flutamide derivativeTesnim Dallagi, Siden Top, Stéphane Masi, et al.
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Chemical Society Reviews|October 22, 2015
Ferrocifen type anti cancer drugsGérard Jaouen, Anne Vessières, Siden Top
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
4-(3-Methoxy-phen-oxy)butyric acidJulia Heilmann-Brohl, Gérard Jaouen, Michael Bolte
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 13, 2005
A new efficient route to chiral 1,3-disubstituted ferrocenes: application to the syntheses of (R(p))- and (S(p))-17alpha-[(3'-formylferrocenyl)ethynyl]estradiolBenoît Ferber, Siden Top, Richard Welter, et al.
Cancers|June 2, 2021
Ferrocifen Loaded Lipid Nanocapsules: A Promising Anticancer Medication against Multidrug Resistant TumorsPierre Idlas, Elise Lepeltier, Gérard Jaouen, et al.
Steroids|January 13, 2004
Are the 11-oxo-steroids really so hindered towards organometallic compounds?Vincent Lecomte, Elie Stéphan, Jacqueline Vaissermann, et al.
The Journal of Organic Chemistry|April 24, 2004
Versatile use of hindered oxalates for the stereoselective preparation of novel 11-modified androst-5-ene derivativesVincent Lecomte, Elie Stéphan, Marie-Noelle Rager, et al.
Dalton Transactions (Cambridge, England : 2003)|May 23, 2012
Targeted therapy vs. DNA-adduct formation-guided design: thoughts about the future of metal-based anticancer drugsGianni Sava, Gérard Jaouen, Elizabeth A Hillard, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|April 11, 2002
FT-IR observation of covalent labelling of lysozyme crystals by organometallic complexes of transition metalsDarren Egan, Michèle Salmain, Patrick McArdle, et al.
Bioconjugate Chemistry|September 22, 2005
Sulfhydryl-selective, covalent labeling of biomolecules with transition metallocarbonyl complexes. Synthesis of (eta5-C5H5)M(CO)3(eta1-N-maleimidato) (M = Mo, W), X-ray structure, and reactivity studiesBogna Rudolf, Marcin Palusiak, Janusz Zakrzewski, et al.
Metallomics : Integrated Biometal Science|November 12, 2010
Synthesis and biodistribution of [99mTc]-N-[4-nitro-3-trifluoromethyl-phenyl] cyclopentadienyltricarbonyltechnetium carboxamide, a nonsteroidal antiandrogen flutamide derivativeTesnim Dallagi, Siden Top, Stéphane Masi, et al.
Pageof 10